{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T05:11:11Z","timestamp":1736658671260,"version":"3.32.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,11]]},"DOI":"10.7759\/cureus.77271","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:29:42Z","timestamp":1736598582000},"source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem Usage in the Initial Antibiotic Therapy of Sepsis in Japanese Intensive Care Units"],"prefix":"10.7759","author":[{"given":"Eri","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Karumai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushimoto","family":"Shigeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukazu","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Mayumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5670238","article-title":"Surveillance of antibiotic prescribing in intensive care units in Poland","volume":"2018","author":"Trejnowska E","year":"2018","unstructured":"Trejnowska E, Deptu\u0142a A, Tarczy\u0144ska-S\u0142omian M, et al.. Surveillance of antibiotic prescribing in intensive care units in Poland. Can J Infect Dis Med Microbiol. 2018, 2018:5670238. 10.1155\/2018\/5670238","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref2","article-title":"Antibiotic prescription in intensive care units in Latin America","volume":"43","author":"Curcio DJ","year":"2011","unstructured":"Curcio DJ. Antibiotic prescription in intensive care units in Latin America. Rev Argent Microbiol. 2011, 43:203-11.","journal-title":"Rev Argent Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.01.022","article-title":"A nationwide survey of intravenous antimicrobial use in intensive care units in Japan","volume":"51","author":"Ohnuma T","year":"2018","unstructured":"Ohnuma T, Hayashi Y, Yamashita K, Marquess J, Lefor AK, Sanui M. A nationwide survey of intravenous antimicrobial use in intensive care units in Japan. Int J Antimicrob Agents. 2018, 51:636-41. 10.1016\/j.ijantimicag.2018.01.022","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush K","year":"2016","unstructured":"Bush K, Bradford PA. \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016, 6:a025247. 10.1101\/cshperspect.a025247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0858","article-title":"Surveillance of antibiotic use and resistance in intensive care units (SARI). A 15-year cohort study","volume":"114","author":"Remschmidt C","year":"2017","unstructured":"Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in intensive care units (SARI). A 15-year cohort study. Dtsch Arztebl Int. 2017, 114:858-65. 10.3238\/arztebl.2017.0858","journal-title":"Dtsch Arztebl Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2013.04.004","article-title":"Antibiotic consumption and resistance: data from Europe and Germany","volume":"303","author":"Meyer E","year":"2013","unstructured":"Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013, 303:388-95. 10.1016\/j.ijmm.2013.04.004","journal-title":"Int J Med Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.46.2001537","article-title":"Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018","volume":"26","author":"Barnsteiner S","year":"2021","unstructured":"Barnsteiner S, Baty F, Albrich WC, et al.. Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill. 2021, 26:1-11. 10.2807\/1560-7917.ES.2021.26.46.2001537","journal-title":"Euro Surveill"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12432","article-title":"Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study","volume":"41","author":"Mladenovic-Antic S","year":"2016","unstructured":"Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, Dinic M, Petrovic J, Randjelovic G, Mitic R. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther. 2016, 41:532-7. 10.1111\/jcpt.12432","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(12)70006-7","article-title":"Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010","volume":"40","author":"Ho CM","year":"2012","unstructured":"Ho CM, Ho MW, Liu YC, et al.. Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010. Int J Antimicrob Agents. 2012, 40:24-8. 10.1016\/S0924-8579(12)70006-7","journal-title":"Int J Antimicrob Agents"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2293-6","article-title":"Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013)","volume":"34","author":"Zou YM","year":"2015","unstructured":"Zou YM, Ma Y, Liu JH, et al.. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis. 2015, 34:795-803. 10.1007\/s10096-014-2293-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2019.74","article-title":"Antibiotic stewardship in the intensive care unit: challenges and opportunities","volume":"40","author":"Chiotos K","year":"2019","unstructured":"Chiotos K, Tamma PD, Gerber JS. Antibiotic stewardship in the intensive care unit: challenges and opportunities. Infect Control Hosp Epidemiol. 2019, 40:693-8. 10.1017\/ice.2019.74","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx181","article-title":"Sparing carbapenem usage","volume":"72","author":"Wilson AP","year":"2017","unstructured":"Wilson AP. Sparing carbapenem usage. J Antimicrob Chemother. 2017, 72:2410-7. 10.1093\/jac\/dkx181","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0480-6","article-title":"Antibiotic stewardship in the intensive care unit","volume":"18","author":"Luyt CE","year":"2014","unstructured":"Luyt CE, Br\u00e9chot N, Trouillet JL, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014, 18:480. 10.1186\/s13054-014-0480-6","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7326\/M13-3016","article-title":"Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use","volume":"161","author":"Lee TC","year":"2014","unstructured":"Lee TC, Frenette C, Jayaraman D, Green L, Pilote L. Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med. 2014, 161:S53-8. 10.7326\/M13-3016","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix606","article-title":"Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: results from the INCREMENT cohort","volume":"65","author":"Palacios-Baena ZR","year":"2017","unstructured":"Palacios-Baena ZR, Guti\u00e9rrez-Guti\u00e9rrez B, Calbo E, et al.. Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: results from the INCREMENT cohort. Clin Infect Dis. 2017, 65:1615-23. 10.1093\/cid\/cix606","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2186-7","article-title":"Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study","volume":"22","author":"Abe T","year":"2018","unstructured":"Abe T, Ogura H, Shiraishi A, et al.. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care. 2018, 22:322. 10.1186\/s13054-018-2186-7","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy MM","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, et al.. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31:1250-6. 10.1097\/01.CCM.0000050454.01978.3B","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger RP","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41:580-637. 10.1097\/CCM.0b013e31827e83af","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes A","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017, 45:486-552. 10.1097\/CCM.0000000000002255","journal-title":"Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-014-0055-2","article-title":"The Japanese guidelines for the management of sepsis","volume":"2","author":"Oda S","year":"2014","unstructured":"Oda S, Aibiki M, Ikeda T, et al.. The Japanese guidelines for the management of sepsis. J Intensive Care. 2014, 2:55. 10.1186\/s40560-014-0055-2","journal-title":"J Intensive Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06035-5","article-title":"Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan","volume":"21","author":"Moriyama Y","year":"2021","unstructured":"Moriyama Y, Ishikane M, Kusama Y, Matsunaga N, Tajima T, Hayakawa K, Ohmagari N. Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan. BMC Infect Dis. 2021, 21:355. 10.1186\/s12879-021-06035-5","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207017","article-title":"Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: a national questionnaire survey in 2017","volume":"13","author":"Kamata K","year":"2018","unstructured":"Kamata K, Tokuda Y, Gu Y, Ohmagari N, Yanagihara K. Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: a national questionnaire survey in 2017. PLoS One. 2018, 13:e0207017. 10.1371\/journal.pone.0207017","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz016","article-title":"Misuse of discharge antimicrobial prescription in the emergency department: an observational study at a tertiary care center","volume":"6","author":"Tagashira Y","year":"2019","unstructured":"Tagashira Y, Yamane N, Miyahara S, Orihara A, Uehara Y, Hiramatsu K, Honda H. Misuse of discharge antimicrobial prescription in the emergency department: an observational study at a tertiary care center. Open Forum Infect Dis. 2019, 6:ofz016. 10.1093\/ofid\/ofz016","journal-title":"Open Forum Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/cc11197","article-title":"Early use of imipenem\/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial","volume":"16","author":"Kim JW","year":"2012","unstructured":"Kim JW, Chung J, Choi SH, Jang HJ, Hong SB, Lim CM, Koh Y. Early use of imipenem\/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial. Crit Care. 2012, 16:R28. 10.1186\/cc11197","journal-title":"Crit Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.08.005","article-title":"Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study","volume":"26","author":"Oi I","year":"2020","unstructured":"Oi I, Ito I, Tanabe N, et al.. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study. J Infect Chemother. 2020, 26:181-7. 10.1016\/j.jiac.2019.08.005","journal-title":"J Infect Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa570","article-title":"Significant regional differences in antibiotic use across 576 us hospitals and 11 701 326 adult admissions, 2016-2017","volume":"73","author":"Goodman KE","year":"2021","unstructured":"Goodman KE, Cosgrove SE, Pineles L, et al.. Significant regional differences in antibiotic use across 576 us hospitals and 11 701 326 adult admissions, 2016-2017. Clin Infect Dis. 2021, 73:213-22. 10.1093\/cid\/ciaa570","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/cc9961","article-title":"Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units","volume":"15","author":"Montravers P","year":"2011","unstructured":"Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care. 2011, 15:R17. 10.1186\/cc9961","journal-title":"Crit Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.639207","article-title":"Variations in the consumption of antimicrobial medicines in the European region, 2014-2018: findings and implications from ESAC-Net and WHO Europe","volume":"12","author":"Robertson J","year":"2021","unstructured":"Robertson J, Vlahovi\u0107-Pal\u010devski V, Iwamoto K, et al.. Variations in the consumption of antimicrobial medicines in the European region, 2014-2018: findings and implications from ESAC-Net and WHO Europe. Front Pharmacol. 2021, 12:639207. 10.3389\/fphar.2021.639207","journal-title":"Front Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00327-19","article-title":"Trends in and predictors of carbapenem consumption across North American hospitals: results from a multicenter survey by the MAD-ID Research Network","volume":"63","author":"Rhodes NJ","year":"2019","unstructured":"Rhodes NJ, Wagner JL, Davis SL, Bosso JA, Goff DA, Rybak MJ, Scheetz MH. Trends in and predictors of carbapenem consumption across North American hospitals: results from a multicenter survey by the MAD-ID Research Network. Antimicrob Agents Chemother. 2019, 63:1-14. 10.1128\/AAC.00327-19","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300901-carbapenem-usage-in-the-initial-antibiotic-therapy-of-sepsis-in-japanese-intensive-care-units","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:29:43Z","timestamp":1736598583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300901-carbapenem-usage-in-the-initial-antibiotic-therapy-of-sepsis-in-japanese-intensive-care-units"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.77271","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}